Volume 11, Issue 2, Pages (February 2005)

Slides:



Advertisements
Similar presentations
Date of download: 10/3/2017 Copyright © ASME. All rights reserved.
Advertisements

Volume 9, Issue 2, Pages (February 2004)
Volume 8, Issue 2, Pages (August 2003)
Date of download: 11/12/2017 Copyright © ASME. All rights reserved.
Adeno-associated virus serotype 9-mediated overexpression of extracellular superoxide dismutase improves recovery from surgical hind-limb ischemia in.
Protein Diffusion in Living Skeletal Muscle Fibers: Dependence on Protein Size, Fiber Type, and Contraction  Simon Papadopoulos, Klaus D. Jürgens, Gerolf.
Volume 2, Issue 1, Pages (July 2000)
In vivo electroporation of constitutively expressed HIF-1α plasmid DNA improves neovascularization in a mouse model of limb ischemia  Geoffrey O. Ouma,
Volume 2, Issue 3, Pages (September 2000)
An engineered vascular endothelial growth factor-activating transcription factor induces therapeutic angiogenesis in ApoE knockout mice with hindlimb.
Volume 17, Issue 8, Pages (August 2009)
The effects of therapeutic electric stimulation on acute muscle atrophy in rats after spinal cord injury  Akiko Misawa, MD, Yoichi Shimada, MD, PhD, Toshiki.
Effects of N-acetylcysteine on skeletal muscle structure and function in a mouse model of peripheral arterial insufficiency  Bruno T. Roseguini, PhD,
Volume 11, Issue 2, Pages (February 2005)
Volume 17, Issue 8, Pages (August 2009)
Volume 9, Issue 5, Pages (May 2004)
Immediate and long-term effects of ankle-foot orthosis on muscle activity during walking: A randomized study of patients with unilateral foot drop  Johanna.
Volume 11, Issue 1, Pages (January 2005)
Volume 14, Issue 1, Pages (July 2006)
Volume 11, Issue 2, Pages (February 2005)
Hypersensitivity and Loss of Disease Site Targeting Caused by Antibody Responses to PEGylated Liposomes  Adam Judge, Kevin McClintock, Janet R. Phelps,
Muscles of Leg.
Volume 11, Issue 1, Pages (January 2005)
Volume 12, Issue 5, Pages (November 2005)
Volume 26, Issue 2, Pages (February 2018)
Volume 20, Issue 2, Pages (February 2012)
Volume 14, Issue 1, Pages (July 2006)
Volume 10, Issue 2, Pages (August 2004)
Volume 2, Issue 1, Pages (July 2000)
Salvage angiogenesis induced by adenovirus-mediated gene transfer of vascular endothelial growth factor protects against ischemic vascular occlusion 
Volume 4, Issue 6, Pages (December 2001)
Molecular Therapy - Nucleic Acids
Volume 20, Issue 1, Pages (January 2012)
Molecular Therapy - Methods & Clinical Development
The effects of therapeutic electric stimulation on acute muscle atrophy in rats after spinal cord injury  Akiko Misawa, MD, Yoichi Shimada, MD, PhD, Toshiki.
Volume 26, Issue 1, Pages (January 2018)
Kenya Kamimura, Guisheng Zhang, Dexi Liu  Molecular Therapy 
Molecular Therapy  Volume 7, Issue 5, (May 2003) DOI: /S (16)
Volume 12, Issue 6, Pages (December 2005)
Strong Promoters Are the Key to Highly Efficient, Noninflammatory and Noncytotoxic Adenoviral-Mediated Transgene Delivery into the Brain in Vivo  Christian.
Julia Ma, Christophe Pichavant, Haley du Bois, Mital Bhakta, Michele P
Volume 6, Issue 3, Pages (September 2007)
Volume 25, Issue 10, Pages (October 2017)
Donna M. Martin, Yehoash Raphael  Molecular Therapy 
Volume 18, Issue 1, Pages (January 2010)
Ex vivo gene delivery of ephrin-B2 induces development of functional collateral vessels in a rabbit model of hind limb ischemia  Masatake Katsu, MD, Hiroyuki.
Volume 12, Issue 2, Pages (August 2005)
Computer-assisted Hydrodynamic Gene Delivery
Endothelial targeting of the Sleeping Beauty transposon within lung
Plasmid Delivery in Vivo from Porous Tissue-Engineering Scaffolds: Transgene Expression and Cellular Transfection  Jae-Hyung Jang, Christopher B. Rives,
Volume 25, Issue 4, Pages (April 2017)
Volume 12, Issue 4, Pages (October 2005)
Volume 10, Issue 4, Pages (October 2004)
Hypersensitivity and Loss of Disease Site Targeting Caused by Antibody Responses to PEGylated Liposomes  Adam Judge, Kevin McClintock, Janet R. Phelps,
Volume 13, Issue 3, Pages (March 2006)
Volume 10, Issue 2, Pages (August 2004)
Volume 10, Issue 4, Pages (October 2004)
Volume 11, Issue 5, Pages (May 2005)
Immobilization decreases the global rates of protein synthesis and muscle mass, but activates mTOR signaling and cap-dependent translation. Immobilization.
Volume 23, Issue 8, Pages (August 2015)
© 2007 McGraw-Hill Higher Education. All rights reserved.
Volume 11, Issue 3, Pages (March 2005)
Volume 3, Issue 5, Pages (May 2001)
Zhijian Wu, Aravind Asokan, R. Jude Samulski  Molecular Therapy 
Volume 8, Issue 1, Pages (July 2003)
Volume 10, Issue 5, Pages (November 2004)
Volume 11, Issue 2, Pages (February 2005)
Arati Sridharan, Chetan Patel, Jit Muthuswamy 
Volume 17, Issue 8, Pages (August 2009)
Volume 9, Issue 2, Pages (February 2004)
Presentation transcript:

Volume 11, Issue 2, Pages 257-266 (February 2005) Optimization of regional intraarterial naked DNA-mediated transgene delivery to skeletal muscles in a large animal model  Gawiyou Danialou, Alain S. Comtois, Stefan Matecki, Josephine Nalbantoglu, George Karpati, Renald Gilbert, Pascale Geoffroy, Sandra Gilligan, Jean-Francois Tanguay, Basil J. Petrof  Molecular Therapy  Volume 11, Issue 2, Pages 257-266 (February 2005) DOI: 10.1016/j.ymthe.2004.09.016 Copyright © 2004 The American Society of Gene Therapy Terms and Conditions

Fig. 1 (A) Time course of changes in IM pressure within the rat tibialis anterior (TA) and gastrocnemius (GAST) during intraarterial injections. Values for IM pressure were significantly higher in the TA at all time points shown after injection. (B) Quantification of β-gal expression in rat hind limb muscles after pDNA administration into the femoral artery. Both the total number of β-gal-expressing fibers (open bars) and the amount of β-gal protein (filled bars) were significantly greater in the GAST compared to the TA. (C) Relationship between peak IM pressure and the number of β-gal-expressing fibers in rat TA and GAST muscles. Note the significant negative correlation between IM pressure and number of β-gal-expressing fibers, irrespective of the use of histamine. Symbols represent the following: circles, GAST; squares, TA; open symbols, without histamine; filled symbols, with histamine. Molecular Therapy 2005 11, 257-266DOI: (10.1016/j.ymthe.2004.09.016) Copyright © 2004 The American Society of Gene Therapy Terms and Conditions

Fig. 2 (A) Schematic illustration of experimental setup in the pig (BP, arterial blood pressure; CVP, central venous pressure). (B) Representative physiological recordings of IM pressure and hemodynamic variables during 25 ml/kg volume injection into the pig femoral artery. Double-headed arrow indicates the onset of the injection. Molecular Therapy 2005 11, 257-266DOI: (10.1016/j.ymthe.2004.09.016) Copyright © 2004 The American Society of Gene Therapy Terms and Conditions

Fig. 3 Differential effects of intraarterial volume delivery on IM pressure and arterial blood pressure during 12.5 (n = 2), 16 (n = 1), 19 (n = 1), and 25 (n = 2) ml/kg volume administration into the pig femoral artery. Molecular Therapy 2005 11, 257-266DOI: (10.1016/j.ymthe.2004.09.016) Copyright © 2004 The American Society of Gene Therapy Terms and Conditions

Fig. 4 Quantification of (A) total number of β-gal-expressing fibers and (B) β-gal protein, after pDNA administration into the pig femoral artery using an injection volume of either 12.5 or 25 ml/kg. Four muscles were sampled from the anterior compartment (TA; EDL, extensor digitorum longus; PT, peroneus tertius; PL, peroneus longus) as well as the posterior compartment (GAST; SOL, soleus; TC, tibialis caudalis; FDL, flexor digitorum longus) of the pig hind limb. Data represent the average values pooled from all regions (proximal, middle, and distal) of each muscle. Molecular Therapy 2005 11, 257-266DOI: (10.1016/j.ymthe.2004.09.016) Copyright © 2004 The American Society of Gene Therapy Terms and Conditions

Fig. 5 Representative photomicrographs of histochemical staining for β-gal in GAST, SOL, EDL, and TA at the two different injection volumes (12.5 and 25 ml/kg). Magnification is identical for all photomicrographs; scale bar, 1 mm. Molecular Therapy 2005 11, 257-266DOI: (10.1016/j.ymthe.2004.09.016) Copyright © 2004 The American Society of Gene Therapy Terms and Conditions

Fig. 6 Number of β-gal-expressing fibers quantified within proximal, middle, and distal muscle regions under optimized conditions (12.5 ml/kg injection volume). In most cases, there was higher transfection within the more proximal regions of targeted muscles. Molecular Therapy 2005 11, 257-266DOI: (10.1016/j.ymthe.2004.09.016) Copyright © 2004 The American Society of Gene Therapy Terms and Conditions

Fig. 7 (A) Creatine kinase and (B) lactate dehydrogenase activities at 24, 48, 72, and 120 h after injection of either 12.5 or 25 ml/kg volume into the pig femoral artery. The mean data are expressed as a percentage of baseline values obtained for each animal immediately prior to the intraarterial injection. Data include pigs that received intraarterial volume injections without pDNA, which did not differ in their enzyme leakage responses. Molecular Therapy 2005 11, 257-266DOI: (10.1016/j.ymthe.2004.09.016) Copyright © 2004 The American Society of Gene Therapy Terms and Conditions